- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Zika vaccines and therapeutics: landscape analysis and challenges ahead ; volume:16 ; number:1 ; day:6 ; month:6 ; year:2018 ; pages:1-15 ; date:12.2018
BMC medicine ; 16, Heft 1 (6.6.2018), 1-15, 12.2018
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Wilder-Smith, Annelies
- Beteiligte Personen und Organisationen
-
Vannice, Kirsten
Durbin, Anna
Hombach, Joachim
Thomas, Stephen J.
Thevarjan, Irani
Simmons, Cameron P.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1067-x
- URN
-
urn:nbn:de:101:1-2018081122304434883230
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wilder-Smith, Annelies
- Vannice, Kirsten
- Durbin, Anna
- Hombach, Joachim
- Thomas, Stephen J.
- Thevarjan, Irani
- Simmons, Cameron P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Therapeutics, diagnostics, new vaccines, interferon treatment, and plasma proteins : with 16 tables
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Therapeutics, diagnostics, new vaccines, interferon treatment, and plasma proteins : with 16 tables
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics